23andMe founder buys back genetic testing company in second auction
Anne Wojcicki pays $305mn to defeat a previous deal struck with Regeneron Pharmaceuticals
Full Article
23andMe founder buys back genetic testing company in second auction
FT.com
0 shares
1 views
You might like
Related news coverage
23andMe founder says Fortune 500 company backs new buyout offer
Anne Wojcicki calls for fresh bankruptcy auction of genetic testing company after Regeneron won bidding
FT.com